Christophe Douat, CEO of Medincell, said: "The initiation of coverage by Truist Securities is a strong endorsement of Medincell’s potential. It confirms the growing interest in our company ...

Truist Securities, a leading U.S. investment bank with deep expertise in healthcare, has initiated coverage of Medincell The Truist Securities equity research team has issued a “Buy” rating on ...

Christophe Douat, CEO of Medincell, said: “The initiation of coverage by Truist Securities is a strong endorsement of Medincell’s potential. It confirms the growing interest in our company ...

Truist Securities's initiation of coverage comes as Medincell's first approved and marketed product in the United States, UZEDY a 1-month and 2-month subcutaneous risperidone for schizophrenia ...

On Wednesday, Truist Securities initiated coverage on Medincell SA (EPA:MEDCL:FP), assigning a Buy rating and setting a price target of EUR22.00. The new rating underscores the firm’s positive ...

On Wednesday, Truist Securities initiated coverage on Medincell SA (EPA:MEDCL:FP), assigning a Buy rating and setting a price target of EUR22.00. The new rating underscores the firm’s positive outlook ...

On Tuesday, May 27, an analyst from Truist Securities initiated coverage on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with a Buy rating and a price target of $25. Teva Pharma is an ...

This press release contains forward-looking statements, including statements regarding Company’s expectations for (i) the timing, progress and outcome of its clinical trials; (ii) the clinical ...

Fintel reports that on May 13, 2025, Truist Securities initiated coverage of Flagstar Financial, Inc. - Preferred Stock (NYSE:FLG.PRA) with a Hold recommendation. What is the Fund Sentiment?

Fintel reports that on May 28, 2025, Truist Securities initiated coverage of Oxford Industries (NYSE:OXM) with a Hold recommendation. Analyst Price Forecast Suggests 5.44% Downside As of May 7 ...